Evidence map›Paper›PMID 39409877›Full record

ArticleCancers2024

Risk Stratification by Combination of Heart and Lung Dose in Locally Advanced Non-Small-Cell Lung Cancer after Radiotherapy.

Yui Watanabe, Yutaro Koide, Hidetoshi Shimizu, Takahiro Aoyama, Yurika Shindo, Shingo Hashimoto, Hiroyuki Tachibana, Takeshi Kodaira

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yui WatanabeDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.ORCID 0000-0002-1958-8196
Yutaro KoideDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.ORCID 0000-0001-8066-8753
Hidetoshi ShimizuDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.
Takahiro AoyamaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.
Yurika ShindoDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.
Shingo HashimotoDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.
Hiroyuki TachibanaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.
Takeshi KodairaDepartment of Radiation Oncology, Aichi Cancer Center Hospital, Nagoya 464-8681, Aichi, Japan.ORCID 0000-0002-7075-8488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

non-small-cell lung cancerprognostic factorsradiotherapysurvival rates

Identifiers

PMID39409877
PMCPMC11475192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.